Skip to content
Debut-5 (1)_thumb.0000000

Market debut IPO: Clarity Pharmaceuticals (CU6)

Clarity Pharmaceuticals (ASX: CU6) has debuted on the Australian stock exchange today.

Following its debut, shares of Clarity Pharmaceuticals rose 7.15% to $1.5/share following an IPO at $1.40/share raising $92 million.

An increase in listing price is a vote of confidence from the market about the future prospects of the company.

A decrease in the listing price can be interpreted in a number of ways, including whether the IPO was accurately priced.

See more stories like this

    Your Cart
    Your cart is emptyReturn to Shop
      Apply Coupon